Search research articles
Contact Us
Filters
Showing results (111-120 of 171) with videos related to
Page
of 18
Sort By:
BJU International
|
April 1, 2022
High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer
Gideon Ptasznik, Nathan Papa, Brian D Kelly, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2021
Clinical insignificance of [<sup>18</sup>F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
Evyn G Arnfield, Paul A Thomas, Matthew J Roberts, et al.
European Urology Oncology
|
August 24, 2024
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
Daniel Lindsay, Penelope Schofield, Matthew J Roberts, et al.
Medicine and Science in Sports and Exercise
|
September 13, 2023
Are There Interindividual Responses of Cardiovascular Disease Risk Markers to Acute Exercise? A Replicate Crossover Trial
Tonghui Shen, Alice E Thackray, James A King, et al.
Open Forum Infectious Diseases
|
April 27, 2022
Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis
Yukiko Ezure, Veronica Rico, David L Paterson, et al.
Nature Reviews. Urology
|
December 6, 2022
Using PSMA imaging for prognostication in localized and advanced prostate cancer
Matthew J Roberts, Tobias Maurer, Marlon Perera, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
February 11, 2024
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis
Daniel Lindsay, Penelope Schofield, Doreen Nabukalu, et al.
NPJ Precision Oncology
|
September 11, 2023
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints
Arti M Raghubar, Nicholas A Matigian, Joanna Crawford, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2020
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
Matthew J Roberts, Andrew Morton, Peter Donato, et al.
BJU International
|
April 4, 2025
Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis
Matthew J Roberts, Shiksha Arora, Henry H Yao, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 171) with videos related to
Sort By:
Page
of 18
BJU International
|
April 1, 2022
High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer
Gideon Ptasznik, Nathan Papa, Brian D Kelly, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2021
Clinical insignificance of [<sup>18</sup>F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
Evyn G Arnfield, Paul A Thomas, Matthew J Roberts, et al.
European Urology Oncology
|
August 24, 2024
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
Daniel Lindsay, Penelope Schofield, Matthew J Roberts, et al.
Medicine and Science in Sports and Exercise
|
September 13, 2023
Are There Interindividual Responses of Cardiovascular Disease Risk Markers to Acute Exercise? A Replicate Crossover Trial
Tonghui Shen, Alice E Thackray, James A King, et al.
Open Forum Infectious Diseases
|
April 27, 2022
Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis
Yukiko Ezure, Veronica Rico, David L Paterson, et al.
Nature Reviews. Urology
|
December 6, 2022
Using PSMA imaging for prognostication in localized and advanced prostate cancer
Matthew J Roberts, Tobias Maurer, Marlon Perera, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
February 11, 2024
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis
Daniel Lindsay, Penelope Schofield, Doreen Nabukalu, et al.
NPJ Precision Oncology
|
September 11, 2023
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints
Arti M Raghubar, Nicholas A Matigian, Joanna Crawford, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2020
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer
Matthew J Roberts, Andrew Morton, Peter Donato, et al.
BJU International
|
April 4, 2025
Transperineal prostate biopsy under local vs general anaesthesia: a cost-effectiveness analysis
Matthew J Roberts, Shiksha Arora, Henry H Yao, et al.
Page
of 18